IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of newspaper publication of Audited Financial Results for the quarter ended 30th June 202210-08-2022
10-08-2022
Q1FY23 Quarterly Result Announced for IOL Chemicals and Pharmaceuticals Ltd.
IOL Chemicals and Pharmaceuticals announced Q1FY23 Result Net profit of the Company at Rs 34.9 Cr against Rs. 27.8 Cr QoQ and Rs. 67 Cr YoY Total Income stood at Rs 570.2 Cr against Rs. 579.4 Cr QoQ and Rs 524.2 Cr YoY EBITDA at Rs. 61.2 Cr as compared to Rs. 50.1 Cr QoQ and Rs 115.9 Cr YoY Commenting on the performance of the Company during the quarter, Dr Sanjay Chaturvedi, Executive Director & CEO said, “Over the next few years, our focus will be on diversifying into other speciality chemical products and increase the share of non-Ibuprofen business. The investment planned in setting up a new plant will aid the Company in strengthening its position in both, Domestic and Export markets, thereby helping in improving our market share. Over the course of next few quarters, the Company’s plan to explore new geographies and de-risk the business with continuous backward integration model will play out leading to improvement in revenue as well as profitability.” “Various business challenges of softening demand, rising inputs costs and volatility in chemical prices are slowly getting normalised as can be seen from recovery in EBITDA margins. However, we believe that the challenges are a temporary phenomenon. The robust global demand on specialty chemicals fronts owing to shift in market share from China would benefit the sector over next few years”, Dr Chaturvedi said. Result PDF10-08-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
IOL Chemicals and Pharmaceuticals Reports Q1 FY23 Results10-08-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 9Th August 2022 And Submission Of Audited Financial Results For The Quarter Ended 30Th June 2022
Outcome of the Board Meeting dated 9th August 2022 and submission of Audited Financial Results for the quarter ended 30th June 202209-08-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Audited Financial Results For The Quarter Ended 30Th June 2022
Outcome of the Board Meeting dated 9th August 2022 and submission of Audited Financial Results for the quarter ended 30th June 202209-08-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of analyst/ investors conference call - 1Q FY2309-08-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in Newspapers04-08-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates04-08-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Reg. 34 (1) Annual Report.
This is in furtherance to our letter dated 30th May 2022, wherein we had informed that the 35th Annual General Meeting (AGM) of the Company will be held on Friday, 26th August 2022 at 11:00 AM (IST) through Video Conferencing / Other Audio Visual Means ('VC/ OAVM'). Pursuant to Regulation 34 (1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith Annual Report of the Company for the financial year 2021-22 including the Notice of AGM containing all the businesses to be transacted at the AGM. The Annual Report including the Notice of AGM is also available on the website of the Company at https://www.iolcp.com/investors/annual-reports03-08-2022
IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in Newspapers01-08-2022